flag flag  

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy

Description : Background: This collaboration of seven observational clinical cohorts investigated risk factors for treatment-limiting toxicities in both anti retroviral-naive and experienced patients starting nevirapine-based combination antiretroviral therapy (NVPc).Methods: Patients starting NVPc after 1 Januar...
Language(s) : Undetermined
Subject(s) : CD4 cell count, HIV, nevirapine, toxicity, viral load, HIV-INFECTED PATIENTS, CD4 CELL COUNTS, PROTEASE INHIBITORS, HIV-1-INFECTED PATIENTS, PROSPECTIVE COHORT, CONTROLLED TRIAL, DOUBLE-BLIND, HYPERSENSITIVITY, RASH, HEPATOTOXICITY
Publisher(s) : LIPPINCOTT WILLIAMS & WILKINS
Contributor(s) :
Source(s) :
Publication Date(s) : 2009-08-24